Healthcare Global Enterprises Limited has informed the Exchange about execution of supplementary agreement to the share purchase agreement between Aceso Company Pte. Ltd. ( Seller ), Hector Asia Holdings II Pte. Ltd. ( Purchaser 1 ) and KIA EBT II Scheme 1 ( Purchaser 2 ) (Purchaser 1 and Purchaser 2 collectively, Purchasers ) and HealthCare Global Enterprises Limited ( Company ) for the sale of upto 54% of the diluted voting share capital of the Company from Seller to the Purchasers ( SPA ) and supplementary agreement to the promoter agreement between the Company, BSA Promoter Group (i.e. Dr. B.S. Ajaikumar, Ms. Bhagya A Ajaikumar, Ms. Anjali Ajaikumar Rossi, Ms. Aagnika Ajaikumar and Ms. Asmitha Ajaikumar) and the Purchasers, to record the inter-se rights and obligations of the Purchasers and the BSA Promoter Group ( Promoter Agreement ), on May 30, 2025.
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.5 pts more than Nifty Microcap 250 and 2.0 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Healthcare Global Enterprises Limited (HCG) has informed the exchange that on May 30, 2025, supplementary agreements were executed to the existing Share Purchase Agreement (SPA) and Promoter Agreement. Under the original SPA, Aceso Company Pte. Ltd. (Seller) is selling up to 54% of the company's diluted voting share capital to Hector Asia Holdings II Pte. Ltd. and KIA EBT II Scheme 1 (collectively the Purchasers). A separate supplementary agreement to the Promoter Agreement records the inter-se rights and obligations between the Purchasers and the BSA Promoter Group (Dr. B.S. Ajaikumar and family members). This represents a significant change of control transaction involving the oncology hospital chain.
This is a major ownership restructuring — up to 54% of HCG's voting capital is changing hands from the existing PE seller to new investors, which is likely to trigger a mandatory open offer under SEBI Takeover Regulations, giving existing retail shareholders an opportunity to tender shares. The continued involvement of the founding Ajaikumar family under a restructured promoter agreement provides some continuity, but the stock may see heightened volatility and re-rating as the deal progresses.